Rylie M. Hightower

Statistics

Publications

Citations

134

H-Index

Active since

2018

Affiliations

University of Alabama at Birmingham(Current)

Children's of Alabama

Civitan International

Boston Children's Hospital

Harvard Stem Cell Institute

Rylie M. Hightower is an author at University of Alabama at Birmingham specializing in muscular dystrophy, molecular biology, and muscular dystrophy pathophysiology.

ORCID

Publications per year

2018–2022

Publications

miR-486 is essential for muscle function and suppresses a dystrophic transcriptome

Adrienne Samani, Rylie M. Hightower, Andrea L. Reid et al. · Life Science Alliance · 2022 · 41 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies

Peter R. Serafini, Michael Feyder, Rylie M. Hightower et al. · JCI Insight · 2018 · 23 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice

Rylie M. Hightower, Andrea L. Reid, Devin Gibbs et al. · Molecular Therapy · 2019 · 23 citations · Full text

Medicine, Molecular Biology, Molecular Medicine +16

Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy

Madhurima Saha, Skylar A. Rizzo, Manashwi Ramanathan et al. · Human Molecular Genetics · 2019 · 17 citations · Full text

Medicine, Genetics, Pharmacology +14

<scp>hnRNP L</scp> is essential for myogenic differentiation and modulates myotonic dystrophy pathologies

Matthew S. Alexander, Rylie M. Hightower, Andrea L. Reid et al. · Muscle & Nerve · 2021 · 16 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

1–5 of 6